Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 223

    1.

    Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death.

    Diamond GA, Bax L, Kaul S.

    Ann Intern Med. 2007 Oct 16;147(8):578-81. Epub 2007 Aug 6.PMID: 17679700 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.

    Dahabreh IJ, Economopoulos K.

    Clin Trials. 2008;5(2):116-20. Erratum in: Clin Trials. 2008;5(5):559. Economopoulos, K [added]. PMID: 18375649 [PubMed - indexed for MEDLINE]Related articles

    3.

    Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes.

    Nissen SE, Wolski K.

    N Engl J Med. 2007 Jun 14;356(24):2457-71. Epub 2007 May 21. Erratum in: N Engl J Med. 2007 Jul 5;357(1):100.. PMID: 17517853 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Rosiglitazone and cardiovascular risk.

    Kaul S, Diamond GA.

    Curr Atheroscler Rep. 2008 Oct;10(5):398-404. Review.PMID: 18706281 [PubMed - indexed for MEDLINE]Related articles

    5.

    Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis.

    Singh S, Loke YK, Furberg CD.

    JAMA. 2007 Sep 12;298(10):1189-95.PMID: 17848653 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Rosiglitazone and cardiovascular risk.

    Diamond GA, Kaul S.

    N Engl J Med. 2007 Aug 30;357(9):938-9; author reply 939-40. No abstract available. PMID: 17806135 [PubMed - indexed for MEDLINE]Related articles

    7.

    The record on rosiglitazone and the risk of myocardial infarction.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jul 5;357(1):67-9. Epub 2007 Jun 5. No abstract available. PMID: 17551162 [PubMed - indexed for MEDLINE]Related articles

    8.

    Rosiglitazone: a thunderstorm from scarce and fragile data.

    Mulrow CD, Cornell J, Localio AR.

    Ann Intern Med. 2007 Oct 16;147(8):585-7. No abstract available. PMID: 17938398 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Rosiglitazone and cardiovascular risk.

    Mannucci E, Monami M, Marchionni N.

    N Engl J Med. 2007 Aug 30;357(9):938; author reply 939-40. No abstract available. PMID: 17806136 [PubMed - indexed for MEDLINE]Related articles

    11.

    Rosiglitazone and cardiovascular risk.

    Psaty BM, Furberg CD.

    N Engl J Med. 2007 Jun 14;356(24):2522-4. Epub 2007 May 21. No abstract available. PMID: 17517854 [PubMed - indexed for MEDLINE]Related articles

    12.

    Rosiglitazone and cardiovascular disease: a cardiologist's perspective.

    Marx N.

    Diab Vasc Dis Res. 2007 Jun;4(2):80-1. No abstract available. PMID: 17654439 [PubMed - indexed for MEDLINE]Related articles

    13.

    Rosiglitazone and cardiovascular disease: an epidemiologist's perspective.

    McGuire DK.

    Diab Vasc Dis Res. 2007 Jun;4(2):77-9. No abstract available. PMID: 17654438 [PubMed - indexed for MEDLINE]Related articles

    14.

    Pioglitazone and the risk of myocardial infarction and other major adverse cardiac events: a meta-analysis of randomized, controlled trials.

    Nagajothi N, Adigopula S, Balamuthusamy S, Velazquez-Cecena JL, Raghunathan K, Khraisat A, Singh S, Molnar J, Khosla S, Benatar D.

    Am J Ther. 2008 Nov-Dec;15(6):506-11.PMID: 19127132 [PubMed - indexed for MEDLINE]Related articles

    15.

    [Therapy with glitazones--a risk for cardiovascular disease?]

    Rottlaender D, Michels G, Erdmann E, Hoppe UC.

    Dtsch Med Wochenschr. 2007 Dec;132(49):2629-32. Review. German. PMID: 18050028 [PubMed - indexed for MEDLINE]Related articles

    16.

    Rosiglitazone and cardiovascular risk.

    Bracken MB.

    N Engl J Med. 2007 Aug 30;357(9):937-8; author reply 939-40. No abstract available. PMID: 17761600 [PubMed - indexed for MEDLINE]Related articles

    17.

    The safety of rosiglitazone in the treatment of type 2 diabetes.

    Singh S, Loke YK.

    Expert Opin Drug Saf. 2008 Sep;7(5):579-85. Review.PMID: 18759710 [PubMed - indexed for MEDLINE]Related articles

    18.

    Faster publication isn't always better.

    Fuster V, Farkouh ME.

    Nat Clin Pract Cardiovasc Med. 2007 Jul;4(7):345. No abstract available. PMID: 17589426 [PubMed - indexed for MEDLINE]Related articles

    19.

    Winners and losers at the rosiglitazone gamble A meta-analytical approach at the definition of the cardiovascular risk profile of rosiglitazone.

    Monami M, Marchionni N, Mannucci E.

    Diabetes Res Clin Pract. 2008 Oct;82(1):48-57. Epub 2008 Sep 4.PMID: 18775581 [PubMed - indexed for MEDLINE]Related articles

    20.

    Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials.

    Lincoff AM, Wolski K, Nicholls SJ, Nissen SE.

    JAMA. 2007 Sep 12;298(10):1180-8.PMID: 17848652 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data